19 June 2013
Keywords: Silence Therapeutics, Mergers and acquisitions, Dainippon
Article | 01 October 2009
London, UK-based Silence Therapeutics has revealed that the company is in merger discussions, without naming the potential partner. The company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2009
18 June 2013
© 2013 thepharmaletter.com